Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer is a research paper published in Cancer Cell (2023). On theSindex it has a DataRank of 0. It has been cited 52 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: T32CA124334
National Cancer Institute
Grant: R00CA218885
National Cancer Institute
Grant: 1P30CA142543
National Cancer Institute
Grant: 1R01CA258584
National Cancer Institute
Grant: 1R01CA245318
National Cancer Institute
Grant: R35CA197311
National Cancer Institute
Grant: R37CA258730
National Cancer Institute
Grant: F31CA261019-01A1
Terry Fox Foundation
Grant: 1090 P3
Welch Foundation
Grant: I-1961-20210327
Welch Foundation
Grant: I-2005-20190330
US Department of Defense
Grant: W81XWH21-1-0520
US Department of Defense
Grant: W81XWH-18-1-0411
US Department of Defense
Grant: W81XWH2110418
Cancer Prevention and Research Institute of Texas
Grant: RR170079
Cancer Prevention and Research Institute of Texas
Grant: RP220309
Cancer Prevention and Research Institute of Texas
Grant: RP190208
Cancer Prevention and Research Institute of Texas
Grant: RP220473
Cancer Prevention and Research Institute of Texas
Grant: RR170050
NCI NIH HHS
Grant: F99 CA223063
NCI NIH HHS
Grant: R01 CA245318
NCI NIH HHS
Grant: F31 CA261019
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: P30 CA142543
NCI NIH HHS
Grant: R01 CA258584
Damon Runyon Cancer Research Foundation
Prostate Cancer Foundation
Howard Hughes Medical Institute
Terry Fox Foundation
MeSH Terms
Keywords